Oya M - Search Results

1

Selective killing of castration-resistant prostate cancer cells by formycin A via the ATF4-CHOP axis.

Takei T, Hamamura Y, Hongo H, Tashiro E, Imoto M, Kosaka T, Oya M. Takei T, et al. Among authors: oya m. Cancer Sci. 2024 Sep 26. doi: 10.1111/cas.16349. Online ahead of print. Cancer Sci. 2024. PMID: 39327674 Free article.

2

Metastatic type-2 papillary renal cell carcinoma responded to interleukin-2 therapy: case report.

Kosaka T, Mikami S, Miyajima A, Oya M. Kosaka T, et al. Among authors: oya m. Clin Exp Nephrol. 2008 Apr;12(2):155-158. doi: 10.1007/s10157-007-0025-2. Epub 2008 Jan 22. Clin Exp Nephrol. 2008. PMID: 18209950

3

Papillary renal cell carcinoma: clinicopathological characteristics in 40 patients.

Kosaka T, Mikami S, Miyajima A, Kikuchi E, Nakagawa K, Ohigashi T, Nakashima J, Oya M. Kosaka T, et al. Among authors: oya m. Clin Exp Nephrol. 2008 Jun;12(3):195-9. doi: 10.1007/s10157-008-0041-x. Epub 2008 Mar 7. Clin Exp Nephrol. 2008. PMID: 18324351

4

The novel NF-kappaB activation inhibitor dehydroxymethyl-epoxyquinomicin suppresses anti-Thy1.1-induced glomerulonephritis in rats.

Kosaka T, Miyajima A, Kikuchi E, Horiguchi Y, Umezawa K, Ohigashi T, Nakashima J, Asano T, Oya M. Kosaka T, et al. Among authors: oya m. Nephron Exp Nephrol. 2008;110(1):e17-24. doi: 10.1159/000150314. Epub 2008 Aug 6. Nephron Exp Nephrol. 2008. PMID: 18685260

5

Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis.

Mikami S, Oya M, Shimoda M, Mizuno R, Ishida M, Kosaka T, Mukai M, Nakajima M, Okada Y. Mikami S, et al. Among authors: oya m. Clin Cancer Res. 2008 Oct 1;14(19):6055-61. doi: 10.1158/1078-0432.CCR-08-0750. Epub 2008 Sep 22. Clin Cancer Res. 2008. PMID: 18809970

6

Angiotensin II type 1 receptor antagonist enhances cis-dichlorodiammineplatinum-induced cytotoxicity in mouse xenograft model of bladder cancer.

Kosugi M, Miyajima A, Kikuchi E, Kosaka T, Horiguchi Y, Murai M, Oya M. Kosugi M, et al. Among authors: oya m. Urology. 2009 Mar;73(3):655-60. doi: 10.1016/j.urology.2008.10.031. Epub 2009 Jan 23. Urology. 2009. PMID: 19167032

7

Renal damage inhibited in mice lacking angiotensinogen gene subjected to unilateral ureteral obstruction.

Uchida Y, Miyajima A, Kikuchi E, Kozakai N, Kosaka T, Ieda M, Fukuda K, Ohigashi T, Oya M. Uchida Y, et al. Among authors: oya m. Urology. 2009 Oct;74(4):938-43. doi: 10.1016/j.urology.2009.02.059. Epub 2009 May 9. Urology. 2009. PMID: 19428059

8

Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.

Mikami S, Katsube K, Oya M, Ishida M, Kosaka T, Mizuno R, Mochizuki S, Ikeda T, Mukai M, Okada Y. Mikami S, et al. Among authors: oya m. J Pathol. 2009 Aug;218(4):530-9. doi: 10.1002/path.2567. J Pathol. 2009. PMID: 19455604

9

Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital Cancer.

Miyajima A, Kikuchi E, Kosaka T, Oya M. Miyajima A, et al. Among authors: oya m. Rev Recent Clin Trials. 2009 May;4(2):75-8. doi: 10.2174/157488709788185996. Rev Recent Clin Trials. 2009. PMID: 19463103 Review.

10

Brain metastasis of a papillary renal cell carcinoma, identified as type 2.

Hasegawa M, Kikuchi E, Yasumizu Y, Hattori S, Takeda T, Morita S, Kosaka T, Miyajima A, Horiguchi T, Mikami S, Oya M. Hasegawa M, et al. Among authors: oya m. Int J Clin Oncol. 2009 Jun;14(3):270-2. doi: 10.1007/s10147-008-0840-9. Epub 2009 Jul 11. Int J Clin Oncol. 2009. PMID: 19593623

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,233 results

Search Page

Filters